lorazepam has been researched along with HIV Coinfection in 3 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " 160 children aged over 2 months with seizures persisting for more than 5 min were randomly assigned to receive either intranasal lorazepam (100 microg/kg, n=80) or intramuscular paraldehyde (0." | 5.12 | Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. ( Ahmad, S; Ellis, JC; Kamwendo, H; Molyneux, E, 2006) |
| "A 24-year old woman with multisubstance use since the age of 13, including opioids and cocaine, and long-standing HIV/HCV seropositivity status, presented with psychosis, agitation, and insomnia at the emergency department of a university hospital." | 1.43 | Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths. ( Calabrò, G; Caloro, M; Corkery, JM; Cuomo, I; De Filippis, S; de Pisa, E; Di Tommaso, A; Girardi, P; Kotzalidis, GD; Lionetto, L; Locatelli, CA; Lonati, D; Ranieri, V; Schifano, F; Vento, AE, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saloner, R | 1 |
| Grelotti, DJ | 1 |
| Tyree, G | 1 |
| Sundermann, EE | 1 |
| Ma, Q | 1 |
| Letendre, S | 1 |
| Heaton, RK | 1 |
| Cherner, M | 1 |
| Caloro, M | 1 |
| Calabrò, G | 1 |
| Kotzalidis, GD | 1 |
| Cuomo, I | 1 |
| Corkery, JM | 1 |
| Vento, AE | 1 |
| Lionetto, L | 1 |
| De Filippis, S | 1 |
| Ranieri, V | 1 |
| Lonati, D | 1 |
| Locatelli, CA | 1 |
| de Pisa, E | 1 |
| Di Tommaso, A | 1 |
| Girardi, P | 1 |
| Schifano, F | 1 |
| Ahmad, S | 1 |
| Ellis, JC | 1 |
| Kamwendo, H | 1 |
| Molyneux, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Trial to Compare the Efficacy and Safety of Intranasal Lorazepam and Intramuscular Paraldehyde in the Treatment of Convulsions in Children[NCT00116064] | Phase 3 | 156 participants | Interventional | 2004-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lorazepam and HIV Coinfection
| Article | Year |
|---|---|
Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial.
Topics: Administration, Intranasal; Anticonvulsants; Child, Preschool; Emergency Service, Hospital; Female; | 2006 |
2 other studies available for lorazepam and HIV Coinfection
| Article | Year |
|---|---|
Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.
Topics: Adult; Aged; Alprazolam; Benzodiazepines; Cross-Sectional Studies; Diazepam; Executive Function; Fem | 2019 |
Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths.
Topics: Adult; Anti-Anxiety Agents; Anti-Retroviral Agents; Antipsychotic Agents; Female; Glycine; HIV Infec | 2016 |